Publications
NCODA’s publication series are comprehensive resources dedicated to advancing clinical education, sharing critical updates, and fostering professional development for all members of the medically integrated oncology team. Tailored for oncology medical professionals, our publications cover essential topics ranging from innovative treatment approaches and pharmaceutical advancements to patient advocacy and leadership in oncology care. Through expert perspectives, case studies, and interdisciplinary insights, we strive to enhance collaboration, improve patient outcomes, and support career growth within the oncology community.
Essential Resources for Oncology Professionals
Oncolytics Today – Spring 2026 Issue
The Spring 2026 edition of Oncolytics Today is here! From access and workflow to emerging therapies and veterans’ care, this issue looks at what oncology teams are navigating every day. All grounded in real-world practice.
Explore the stories, insights, and innovations shaping cancer care today.
Oncolytics Today Spring 2026
Oncolytics Today
Oncolytics Today
Oncolytics Today Fall 2025
A New Way to Treat Brain Cancer? A Phase 1 clinical trial explored the use of Rhenium (186Re) Obisbemeda (186RNL) for treating recurrent glioma, demonstrating its potential to deliver high radiation doses with minimal toxicity. The promising results, particularly in patients receiving higher doses, set the stage for further evaluation in Phase 2 trials.
October 3, 2025
Oncolytics Today
Oncolytics Today Spring 2025
A New Way to Treat Brain Cancer? A Phase 1 clinical trial explored the use of Rhenium (186Re) Obisbemeda (186RNL) for treating recurrent glioma, demonstrating its potential to deliver high radiation doses with minimal toxicity. The promising results, particularly in patients receiving higher doses, set the stage for further evaluation in Phase 2 trials.
April 21, 2025
Oncolytics Today
Oncolytics Today Fall 2024
THE BISPECIFIC ANTIBODY REVOLUTION: Breakthroughs in research have led to a host of new cellular therapies. In this issue of Oncolytics Today, we take a look at recently approved BsAbs as well as advances in tumor-infiltrating lymphocytes, antibody-drug conjugates and CAR-T therapy.
October 1, 2024
Forum Rewind
Forum Rewind
Forum Rewind 2025
Running Through Life With Purpose and Grace A doctor who survived both stage IV cancer and heart failure now teaches her patients how to live life to the fullest.
May 1, 2025
Forum Rewind
Forum Rewind 2023
Running Through Life With Purpose and Grace A doctor who survived both stage IV cancer and heart failure now teaches her patients how to live life to the fullest.
April 30, 2023
Forum Rewind
Forum Rewind 2022
Diversity, Equity and Inclusion in Cancer Care Resolving healthcare disparities among racial, ethnic and socio-economic groups.
April 30, 2022
Summit Rewind
Summit Rewind
Summit Rewind 2025
SummitRewind features session recaps, key takeaways, and practical insights from the 2025 NCODA Fall Summit.
January 5, 2026
Summit Rewind
Summit Rewind 2024
Champion Mindset: Overcoming Adversity and Tenacity During Challenging Times National Champion/Olympic high jumper Chaunté Lowe provides insight on succeeding while overcoming adversity.
October 31, 2024
Summit Rewind
Summit Rewind 2023
Emerging Therapy of Bispecifics A comprehensive overview for a new class of emerging therapies known as bispecific antibodies (BsAbs).
October 31, 2023
Inspire
